IFNAR1 and infection: Because aggressive recruitment of Gr1 + CD11b + cells was observed after day 3 post-infection (Figure 1E), we wondered whether intranasal treatment with an anti-IFNAR1 blocking antibody at day 3 post-infection could interrupt the influx of CCR2+ inflammatory monocytes.